Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedXV
XTX Ventures
Activity from announced rounds
Activity in this selectionUnited Kingdom · Oct 12, 2026 · Jan 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $71.2M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionValarian
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
$50MSeries A
Role not disclosedQMatter
Develops quantum compression technology to enable computation on existing quantum and classical systems
$1.2MPre-Seed
Role not disclosed